Efforts within the Institute for Bioengineering Research are focused on performing innovative research related to the integration of engineered materials into human physiology and to the development of novel technologies for early-stage diagnosis and management of disease. Engineers, scientists, clinicians and industrial partners work collaboratively to translate basic research to products that will benefit society.
By 2030, the NIH predicts that 72 million Americans will be 65 and older—and nearly 80% of them will suffer a chronic health condition that requires tissue, joint, or organ repair. Biomaterials will be key to meeting this demand. Used in more than 500 million medical devices, biomaterials are critical components of implants, stents, catheters, sensors, and drug-delivery systems. Meeting the unprecedented demand for new biomaterials and medical devices requires strategies that capitalize on the knowledge and expertise of researchers from diverse disciplines―researchers who think like scientists but create like engineers to turn ideas into materials, devices, and therapies that will hopefully change people’s lives. Multi-modal experimental measurements are combined with mathematical modeling to provide insights beyond what could be accomplished if either of the approaches were applied independently. The models are used to predict properties, forecast behavior and promote targeted design optimization.